2m 2m 2m 2m 2m 2m 2m
ORIC PHARMA (ORIC)
NASDAQ
$12.21-$0.31 (-2.52%)
Price as of Oct 02, 2026 4:39 PM EDT- $1.3BMarket Cap
- 10.60%1-Year Change
- BiotechnologyIndustry
ORIC PHARMA (ORIC)
$12.21-$0.31 (-2.52%)
ORIC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $12.52 | ||
Change | -$0.95 (-7.05%) | ||
Open | $13.42 | ||
High | $13.62 | ||
Low | $12.51 | ||
Previous Close | $13.47 | ||
Volume | 1,770,890 | ||
30-Day Average Volume | 1,489,430 | ||
1-Week Change | -5.01% | ||
1-Month Change | -2.87% | ||
1-Year Change | 10.60% | ||
3-Year Change | 106.94% | ||
5-Year Change | -38.33% | ||
Fundamentals | |||
Shares Outstanding | 103.7M | ||
Total Assets | $404.7M | ||
Market Cap | $1.3B | ||
Enterprise Value | $1.3B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$41.5M | ||
Free Cash Flow | -$32.0M | ||
EBIT | -$41.5M | ||
EBITDA | -$41.2M | ||
Net Working Capital | $252.9M | ||
EPS | -$0.38 | ||
Enterprise Value/EBITDA | -31 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -33 | ||
PEG | 3 | ||
Price/Free Cash Flow | -41 | ||
Price/Operating Cash Flow | -41 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue